A Study to Evaluate BMS-986165 Tablet Formulation Relative to BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal and Increased Gastric pH on the BMS-986165 Tablet Formulation
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
Age
18–50
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Patients must be willing and able to complete all study-specific procedures and visits
Healthy patients, as determined by no clinically significant deviation from normal in medical history, physical examination, electrocardiogram, and clinical laboratory determinations
Body mass index (BMI) of 18 to 32 kg/m2, inclusive, at screening
Normal renal function at screening
You may not be if
Women of childbearing potential not using an effective contraceptive method or are breastfeeding
Any significant acute or chronic medical illness
History of chronic headaches, defined as occurring 15 days or more a month, over the previous 3 months
History of headaches related to caffeine withdrawal, including energy drinks
History of syncope, orthostatic instability, or recurrent dizziness
Active TB requiring treatment or documented latent TB within the previous 3 years
Clareo Health | A Study to Evaluate BMS-986165 Tablet Formulation Relative to BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal and Increased Gastric pH on the BMS-986165 Tablet Formulation
